Introduction
Esophageal squamous cell carcinoma (ESCC) is the predominant histological subtype of esophageal cancer and is characterized by a high mortality rate and regional variation in incidence in China (Parkin et al., 1993) . As ESCC is usually diagnosed at a relatively late stage, treatment options are limited and the 5-year survival rate remains low (Montesano et al., 1996) .
Previous work in our lab has shown that a Mendelian autosomal recessive major gene may contribute to genetic susceptibility to ESCC in a moderate highincidence area of Northern China (Zhang et al., 2000) . It is known that complicated genetic alterations occur frequently in ESCC, including allelic loss on chromosomes (17p, 13q, 9p21-22) and mutations of certain known genes (p53, p16) (Lam et al., 1997; Busatto et al., 1998) . In addition, ESCC is related to nutritional deficiencies in calcium, vitamin D 3 and other minerals (Li et al., 1998) . However, the nature of the relationship between genetic and other risk factors remains unclear.
Multiple genes are involved in ESCC, including cyclin D1, EGFR, annexin I, cystatin B, int-2, CASK and keratin 4 (Suzuki et al., 1997; Nagasawa et al., 2001; Wang et al., 2002; Xia et al., 2002) . Several studies on differential gene expression in ESCC using commercially available microarray membranes have been reported Lu et al., 2001; Ishizuka et al., 2002; Xu et al., 2002) . In this study, we analysed the expression profiles of 34 176 clones in ESCC using a high-density cDNA microarray derived from our own cDNA libraries. We identified genes differentially expressed in ESCC, and confirmed the altered gene expression in selected genes by Northern blot and immunohistochemistry analysis. We found that a number of genes involved in squamous cell differentiation were downregulated in ESCC, and we also observed a significant downregulation of genes involved in transcription, translation, protein folding and protease inhibitors. In addition, several upregulated genes are involved in ESCC invasion or proliferation. Although further study on the regulation of differentially expressed genes in ESCC is necessary, these results will help us better understand the process of esophageal tumorigenesis and provide additional markers for the diagnosis and treatment of this disease.
Results

Overview of library quality and expressed sequence tag (EST) expression pattern in ESCC
Our in-house library consists of normalized and sizefiltered cDNA derived from esophageal cancer (ESPC) and esophageal normal (ESPN) tissue; the average insert size is approximately 1.2-1.5 kb (data not shown), in line with the mean size of human mRNAs. After sequencing the transcripts and eliminating repetitive elements and mitochondrial DNA, a total of 1093 genes were analysed. Using a public database search, these were classified as known genes (617, 56.45%), known ESTs (221, 20.22%) and previously uncharacterized ESTs (255, 23.33%). We sorted the 617 known genes into seven categories (or functional groups) according to their biological roles as defined by the GENECARDS database. We used EST data from both the ESPC and ESPN libraries to construct our gene expression profiles. These profiles clearly reflect the functional characteristics of esophagus, in that the majority of the 10 genes were differentially expressed according to their EST copy numbers (Table 1) .
cDNA microarray analysis cDNA microarray technology was used to analyse the gene expression profiles of five esophageal cancer tissue samples and their matched adjacent normal mucosal tissue samples. Differential expression was considered to be significant when the ratio of the signals from tumorous and normal tissues was greater than 2. The cDNA clones with an expression ratio of 3 or greater in four or more paired samples were sequenced for further analysis. Sequence analysis showed 240 clones that formed 92 unique genes. Of these, 60 were previously known genes and the remaining 32 were novel genes. In addition, 77 genes (including 31 novel genes) were downregulated, whereas 15 genes (including one novel gene) were upregulated in five cancer tissue samples. Table 2 summarizes the database search results of the genes with a threefold differential expression in ESCC.
To confirm the altered expression level, five genes were randomly selected and verified by Northern blot. As shown in Figure 1 , Northern blot results were consistent with cDNA microarray results in terms of differential gene expression. Moreover, cDNA microarray and randomly sequenced ESTs consistently showed altered expression in several genes, including KRT4, KRT13, annexin I, eukaryotic translation elongation factor 1 alpha-1 (EEF1A1) and small proline-rich protein 3 (SPRR 3 ).
Alterations of gene expression in ESCC
A group of differentiation-related genes are coordinately downregulated in ESCC tissue samples, including SPRRI, SPRRII, SPRR3, EEF1A1, chromosome 1 open reading frame 10 (C1orf10), Mal T-cell differentiation protein, polycystic kidney disease 1 (PKD1), epithelial membrane protein 1 (EMP1), annexin I, S100A8, transglutaminase 3 (TGM3), gut-enriched Kruppel-like factor (GKLF) and cystatin A. All of these genes are highly expressed in the normal esophagus. Interestingly, most of these genes encode Ca 2 þ -binding or -modulating proteins, which constitute the cell envelope (CE). Moreover, SPRRs and S100 calcium-binding proteins belong to the epidermal differentiation complex (EDC), which is located on chromosome 1q21 and is involved in the terminal differentiation of epithelial cells (Marenholz et al., 1996) .
Cytokeratin expression is a reliable biochemical indicator of the epithelial differentiation process (van Dorst et al., 1998) . Three different cytokeratins, KRT4, KRT13 and KRT15, were found to be downregulated, whereas KRT16 and KRT17 were upregulated in ESCC. It was revealed that the expression of cytokeratins (KRT4 and KRT13) and the cross-linked envelope were aberrant during the different stages of terminal differentiation in ESCC (Banks-Schlegel et al., 1986) . The most striking feature of KRT4 À/À mice is that esophageal epithelial cells do not terminally differentiate, but have abnormal proliferation (Ness et al., 1998) . Our data suggested that the altered expression of several cytokeratins might be associated with the abnormal differentiation and proliferation of ESCC.
Our data also showed that several genes involved in transcription and translation were downregulated in ESCC. Genes associated with transcription were downregulated, including GKLF and an inhibitor of DNA binding 2. EEF1A1 was downregulated; this gene modulates the dynamic behavior of microtubules assembled from tubulin sources and regulates the cell cycle (Moore et al., 1998) . In parallel with the down- Differentiation genes altered in esophageal cancer A Luo et al regulation of EEF1A1, the chaperone, heat shock protein 70, was also downregulated. The metastatic spread of cancer is a complex process that involves the combination of different cellular actions including cell adhesion to the extracellular matrix (ECM) and breakdown of the ECM by specific matrix-degrading proteinases. The protease of cathepsin B was upregulated, whereas cathepsin L was downregulated in ESCC. On the other hand, several protease inhibitors, which were important negative regulators of protease action in vivo, were downregulated in ESCC, including cystatin A, cystatin B and serine (or cysteine) proteinase inhibitor. In contrast, fibronectin and secreted protein acidic and rich in cystein (SPARC) were upregulated in ESCC; these genes are involved in a variety of diverse biological processes, including matrix synthesis/turnover, differentiation, cell adhesion and tumor cell migration and invasion. Our data suggest that the downregulation of protease inhibitors might be associated with ESCC invasion and metastasis.
Immunohistochemistry analysis
To validate our gene expression data, we examined the immunohistochemical staining patterns for three proteins in matched pairs of histologically normal esophageal mucosa and tumorous tissue specimens. The expression level of certain proteins was significantly lower in tumorous tissue as compared with the normal epithelium. We observed decreased expression of annexin I in 28 out of 31 carcinomas, decreased expression of S100A8 in 27 out of 31 carcinomas and decreased expression of S100A9 in 26 out of 33 carcinomas. S100A8 and S100A9 protein expression was found to translocate from the membrane (rarely in cytoplasm) in the normal esophageal epithelium to cytoplasm in tumors at the stage of moderate and poor differentiation. Annexin I was highly expressed in the superficial layer of the esophageal epithelium (Figure 2) .
We then performed statistical analysis with respect to the correlation between the protein expression and the histopathologic differentiation types. S100A8 expression was significantly higher in carcinoma with high differentiation than that with moderate differentiation (P ¼ 0.032), whereas S100A9 and annexin I significantly Figure 1 Northern blot analysis of the differentially expressed genes. S100A8, S100A9, EEF1A1, KRT4 and EMP1 were downregulated in esophageal cancer tissues (C) compared to the matched almost normal tissues (N)
Differentiation genes altered in esophageal cancer A Luo et al decreased from high differentiation to poor differentiation (P ¼ 0.037, 0.003, respectively). The detailed expression patterns, including the percentage of positive cases and the staining intensities, are presented in Table 3 .
Expression of GKLF in KYSE-70 stimulates SPRRs and KRT4 transcription
GKLF, an epithelial cell-enriched zinc finger-containing transcription factor, transcriptionally activates two esophageal epithelial promoters (Epstein-Barr virus ED-L2 and keratin 4), which play an important role Figure 2 Immunostaining showed the expression pattern of S100A8, S100A9 and annexin I in esophageal carcinoma and the matched normal esophageal epithelium. A similar pattern of S100A8 and S100A9 immunoreactivity was observed. S100A8 and S100A9 were predominantly localized in the membrane or cytoplasm and marked in prickle cell, intermediate and superficial layers, whereas they were located in the cytoplasm in the tumor nest. Annexin I was highly expressed in the superficial layer of the esophageal epithelium. N: normal esophageal epithelium; W: highdifferentiated ESCC; M: moderately differentiated ESCC; P: poorly differentiated ESCC Immunohistochemistry analysis showed that the expression levels of annexin I, S100A8 and S100A9 were significantly decreased from the normal epithelium to cancer (Po0.05). The level of S100A8 expression was significantly higher in carcinoma with high differentiation than that with moderate differentiation (P ¼ 0.032), whereas S100A9 and annexin I was significantly decreased from carcinoma with high differentiation to that with poor differentiation (P ¼ 0.037, 0.003, respectively). The mean, average of the integral intensity of all samples: Transient transfection with 2 mg of pcDNA3.1 (control) or pcDNA3.1-GKLF vector in KYSE-70 cell, then total RNA was isolated at the indicated time points and converted to cDNA using Superscript II reverse transcriptase. Expression of SPRR1A, SPRR2A and KRT4 was increased in response to the upregulation of GKLF (c), whereas no changes were observed in KYSE-70 cells transfected with pcDNA3.1 vector control (b). b-actin or GAPDH was used as an internal control Differentiation genes altered in esophageal cancer A Luo et al at the transition toward differentiation (Jenkins et al., 1998) . Since our data show that GKLF, SPRR1A, SPRR2A and KRT4 are all downregulated in ESCC (Figure 3a) , we speculate that GKLF expression might trigger the expression of its target genes in ESCC. The results show that the expression of SPRR1A, SPRR2A and KRT4 are increased in response to the upregulation of GKLF in KYSE-70 cells when transiently transfected with the pcDNA3.1-GKLF vector (Figure 3b and c) .
Discussion
Esophageal mucosa is lined by a stratified squamous epithelium that functions in epithelial proliferation, differentiation and turnover, and serves as a barrier (Geboes et al., 1978) . Cellular proliferation is frequent in the epibasal layers, and loss of contact with the basement membrane eventually triggers differentiation (Seery et al., 2000) and the sequential expression of differentiation markers (Jankowski et al., 1993) . Squamous cell differentiation requires the coordinated activation and repression of genes specific to the differentiation process, and disruption of this program accompanies neoplasia (Jones et al., 1997) . In this study, we used cDNA microarray analysis to profile the changes in gene expression that accompany these processes.
Our genetic profile aims to find correlations between genetic changes and esophageal squamous cell differentiation. Squamous cell differentiation-associated genes were downregulated in ESCC, including TGM3 and its substrates SPRRs, as well as the calcium-binding S100 protein, annexin I, EMP1 and cystatin A, all of which are incorporated into the CE (Steven and Steinert, 1994; Steinert et al., 1998; Marenholz et al., 1996; Robinson et al., 1997) . The CE performs a vital barrier function, and it is constructed through the sequential expression, processing and deposition of several distinct proteins that are cross-linked by transglutaminase. Recently, knockouts of the major CE constituent loricrin and GKLF have both failed to disrupt significantly the barrier function of the skin, and die shortly after birth due to dehydration (Matsuki et al., 1998; Koch et al., 2000) . Our data suggest that the downregulation of squamous cell differentiation-associated genes might lead to the disability of the formation of the CE and sustenance of toxic material.
The reduction of CE-related genes might be relevant to metastasis. To a significant extent, these genes are controlled at the transcriptional level; thus they may have several regulators that we can identify. One possible regulator is calcium, since cells require calcium to induce CE formation and express a number of differentiation-related proteins such as membrane-bound transglutaminase and cytokeratins (Bikle et al., 2001) . The switch between proliferation and differentiation is modulated by calcium (Dotto et al., 1999, review) . Intracellular calcium concentration is transduced by the 'activation' of Ca 2 þ -binding proteins and calcium-and phospholipid-binding proteins of the annexin family (Kerkhoff et al., 1998, review) . Our data show that several members of the annexin and S100 family have significantly decreased expression levels in ESCC. Annexin I and annexin II form Ca 2 þ channels in the plasma membrane, thereby regulating Ca 2 þ homeostasis (Frey et al., 1999) . Annexin I-S100A11 or annexin II-S100A10 form heterotetramer (Thiel et al., 1992) and modulate intracellular calcium concentration. In addition, the COOH-terminal cytoplasmic tail of PKD-1 increases the activity of a Ca 2 þ -permeable cation channel (Hanaoka et al., 2000) .
Epidemiological data show that calcium levels are lower in wheat and maize grown in an area of China whose population is at high risk for ESCC (Lianzhou) compared to the level in wheat and maize from a lower risk area (Yuzhou) in China (Chang et al., 1999) . Our results indicate that calcium might be involved in the progress of ESCC and in esophageal epithelium proliferation and differentiation.
The aberrant expression of squamous cell differentiation-associated genes prompted us to ask whether the regulators of CE formation are defective. Our data show that the expression of GKLF, SPRRs and cytokeratins is altered in ESCC. It is known that GKLF plays an important role in epithelial cell proliferation and/or differentiation (Katz et al., 2002) ; previous studies have shown that SPRR1A and SPRR2A are downregulated in response to the downregulation of GKLF in transgenic mice overexpressing claudin 6, and GKLF À/À mice (Segre et al., 1999; Turksen et al., 2002) . SPRR1A and SPRR2A, the precursor proteins of the CE, are more abundant in the CE of oral and esophageal epithelium (Hohl et al., 1995) . Thus, GKLF may be responsible for the cascade of changes that lead to abnormal expression of differentiation associated genes and disruption of the CE cross-linking process. Furthermore, a common feature of the promoter region of differentiation-associated genes including SPRR1, SPRR3, cystatin A and KRT4, is the presence of AP-1-binding sites Yamazaki et al., 1997; Sark et al., 1998; Fischer et al., 1999) . Further evidence shows that the expression of S100A8, S100A9, cystatin A and SPARC is indirectly regulated by AP-1 (Arnould et al., 1998; Briggs et al., 2002; Gebhardt et al., 2002) ; thus we speculate that AP-1 may participate in the process of altering expression of squamous cell differentiationassociated genes in ESCC.
Our study shows that certain genetic events are altered in ESCC and these markers might have potential diagnostic and biological value in tumor assessment. How squamous cell differentiation-associated genes are regulated, however, is unknown; nor do we know the significance of their positional location on chromosome 1q21. Further investigations will be required to verify the involvement in ESCC of the differentially expressed genes discussed above and to further elucidate the molecular mechanisms of ESCC development.
Materials and methods
Patients and samples
For Northern blot and cDNA microarray analysis, ESPC and matched adjacent normal mucosa tissue samples were taken from patients who had not been treated with radiotherapy or chemotherapy before surgery. Fresh samples were dissected manually to remove mixed connective tissues, and were immediately stored in liquid nitrogen. The samples used for immunohistochemistry analysis were fixed in 4% polyformaldehyde and completely embedded in paraffin.
cDNA libraries
Equal quantities of high-purity undegraded 5 mg of poly(A) þ RNA were extracted using the mRNA purification Kit (Amersham Pharmacia, Inc., Piscataway, NJ, USA) from both cancerous and normal esophagus tissues. The cDNA libraries, ESPN and ESPC, were constructed by using the l-ZAP express vector system (Stratagene, Inc., Kirkland, WA, USA) according to the previously described method (Liew et al., 1997) . Briefly, the first strand cDNA was synthesized using a restriction endonuclease (RE1)-adapted oligo-dT primer. After synthesizing the second strand, RE2 adaptors were then ligated onto the cDNA using T4 DNA ligase. Following adaptor ligation, cDNA was digested, and an RE1 site at the 3 0 -end and an RE2 site at the 5 0 -end were subsequently generated. To increase the fraction of cDNA clones and remove excess adaptor, the cDNA was size fractionated by gel filtration chromatography. After the libraries were constructed, 1584 clones were randomly picked for sequence analysis.
cDNA array construction
The l-ZAP express vector has the advantage of in vivo excision of the insert and flanking sequences into a phagemid. Generally, the libraries had a set of highly abundant genes that were not complex enough to be exploited further by cDNA microarray analysis. Approximately 6.57% of the clones from ESPC and ESPN libraries contained cDNA inserts representing KRT4 and KRT13 according to the ESTs sequencing; thus we subtracted these two genes, and then randomly picked 34 176 cDNA inserts from ESPN and ESPC libraries by PCR amplification with T3 (forward) and T7 (reverse) primers. The amplified cDNA inserts were visually inspected on 1% agarose gels to ensure the quality and quantity of the DNA prior to depositing onto two 8X12 Hybond-N þ nylon membranes (Amersham Pharmacia, Inc., Piscataway, NJ, USA) using a specialized arrayer (Bio Robotics, Inc., Haslingfield, Cambridge, UK). Each cDNA fragment was placed in two different spots (i.e., double offset). Lambda phage and pUC18 vector DNA were spotted as negative controls. Eight housekeeping genes were evenly distributed (12 times each) onto each membrane as an intramembrane control, as previously described by Xu et al. (2001) .
Hybridization and image processing
Total RNA was extracted from frozen tissues by using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA); poly(A) þ mRNA was then isolated from total RNA using a poly(dT) resin. Approximately 1 mg of mRNA was labeled in a reverse transcription reaction in the 200 mCi [a-33 P]dATP using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The hybridization and subsequent imaging was performed using a previously described method (Xu et al., 2001) . Genes with intensities greater than 10 were considered as positive signals to ensure that they were distinguished from the background with statistical significance 499.9%. Normalization among arrays was performed by the intensities of the housekeeping genes on the membranes.
Sequencing analysis of the differentially expressed genes
The clones were chosen for sequencing analysis when the ratio of the signals between the same spot on different membranes was greater than 3. DNA was sequenced using the ABI377 automated sequencer (Perkin-Elmer/Applied Bioasia, Shanghai, China); homology comparison was performed using the BLAST software. The sequences were considered to be part of the known genes if they were at least 95% homologous. ESTs without significant homology were considered as novel genes.
Northern blot and RT-PCR
Genes identified by cDNA microarray were further analysed using Northern blot to confirm their expression profiles. For Northern blot analysis, total RNA (20 mg) was electrophoresed through 1% agarose formaldehyde gel and transferred onto a Hybond-N þ nylon membrane. The membrane was hybridized with the [a-
32 P]dCTP-labeled, random-primed cDNA fragments and visualized by autoradiography. Moreover, 5 mg of total RNA was converted to cDNA using Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA). The relative expression of genes was determined using RT-PCR with bactin or GAPDH as an internal control.
Immunohistochemistry
Paraffin sections (thickness 5 mm) from ESCC patients were treated as described previously (Hsu et al., 1981) followed by incubation with primary antibodies (annexin I, S100A8 and S100A9, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) overnight at 41C in a humid chamber, at the dilutions of 1 : 100 (annexin I), 1 : 200 (S100A8) and 1 : 200 (S100A9), respectively. For negative controls, the primary antibody was replaced by nonimmune serum. After immunostaining, the sections were imaged at magnification ( Â 200) by a single investigator who was not informed of the clinical characteristics; three high-power fields were examined for each section. The value of the integral intensity in these fields was measured by quantification software developed at the Center of Imagine Analysis, Beijing University of Aeronautics and Astronautics. Specimens were classified as 'positive' if 410% of cells displayed a staining intensity. The statistical significance of the relationship between the gene expression pattern and the grade of differentiation was analysed using SPSS 10.0 software.
Cell culture and transient transfection
Human ESCC cell line KYSE-70 was cultured in an RPM1640 medium supplemented with 10% fetal bovine serum. The open reading frame of the GKLF cDNA was subcloned into the mammalian expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA) to generate pcDNA3.1-GKLF. pcDNA3.1-GKLF plasmid DNA was transiently transfected into KYSE-70 cells using lipofectaminet 2000 as recommended by the manufacturer (Invitrogen, Carlsbad, CA, USA). pcDNA3.1 was used as a control for the transfection.
